Cargando…

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study

Background: The androgen receptor (AR) has emerged as a potential therapeutic target for AR-positive triple-negative breast cancer (TNBC). However, conflicting reports regarding AR’s prognostic role in TNBC are putting its usefulness in question. Some studies conclude that AR positivity indicates a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattarai, Shristi, Klimov, Sergey, Mittal, Karuna, Krishnamurti, Uma, Li, Xiaoxian (Bill), Oprea-Ilies, Gabriela, Wetherilt, Ceyda Sonmez, Riaz, Ansa, Aleskandarany, Mohammed A., Green, Andrew R., Ellis, Ian O., Cantuaria, Guilherme, Gupta, Meenakshi, Manne, Upender, Agboola, Johnson, Baskovich, Brett, Janssen, Emiel A. M., Callagy, Grace, Walsh, Elaine M., Mehta, Anurag, Dogra, Atika, Shet, Tanuja, Gajaria, Pooja, Traina, Tiffany, Nggada, Haruna A., Omonisi, Abidemi, Ahmed, Saad A., Rakha, Emad A., Rida, Padmashree, Aneja, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678933/ https://www.ncbi.nlm.nih.gov/pubmed/31319547 http://dx.doi.org/10.3390/cancers11070995

Ejemplares similares

Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
por: Ogden, Angela, et al.
Publicado: (2017)

Machine learning-based prediction of breast cancer growth rate in vivo
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
por: Ogden, Angela, et al.
Publicado: (2020)

Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives
por: Wright, Nikita, et al.
Publicado: (2018)

Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations
por: Wright, Nikita, et al.
Publicado: (2017)

A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
por: Klimov, Sergey, et al.
Publicado: (2019)

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015)

Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells
por: Mittal, Karuna, et al.
Publicado: (2017)

How COVID-19 pandemic is changing the Africa’s elaborate burial rites, mourning and grieving
por: Omonisi, Abidemi Emmanuel
Publicado: (2020)

A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas
por: Mittal, Karuna, et al.
Publicado: (2016)

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis
por: Klimov, Sergey, et al.
Publicado: (2021)

Skin and Soft Tissue Lesions in a District Hospital in Central Nigeria: A Histopathological Study
por: Duduyemi, Babatunde M., et al.
Publicado: (2019)

KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
por: Pawar, Shrikant, et al.
Publicado: (2014)

Population-Based Cancer Registration in Sub-Saharan Africa: Its Role in Research and Cancer Control
por: Omonisi, Abidemi Emmanuel, et al.
Publicado: (2020)

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
por: Fisher, Timothy B., et al.
Publicado: (2023)

Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
por: Mittal, Karuna, et al.
Publicado: (2022)

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients
por: Xu, Qi, et al.
Publicado: (2022)

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer
por: Garlapati, Chakravarthy, et al.
Publicado: (2023)

Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
por: Ogden, Angela, et al.
Publicado: (2017)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Aspirin-Induced Gastric Lesions Alters EGFR and PECAM-1 Immunoreactivity in Wistar Rats: Modulatory Action of Flavonoid Fraction of Musa Paradisiaca
por: Alese, Margaret Olutayo, et al.
Publicado: (2017)

The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
por: Mahathre, Monica M., et al.
Publicado: (2016)

HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
por: Pannu, Vaishali, et al.
Publicado: (2015)

Panoptic View of Prognostic Models for Personalized Breast Cancer Management
por: Saini, Geetanjali, et al.
Publicado: (2019)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

Incidental carcinoma of the prostate gland presenting with initial manifestation of disseminated intravascular coagulopathy (dic) in a middle aged man: a case report
por: Salako, Ayo Abdulkadir, et al.
Publicado: (2009)

The pathogenicity of Staphylococcus epidermidis on the intestinal organs of rats and mice: an experimental investigation
por: Akinkunmi, Ezekiel Olugbenga, et al.
Publicado: (2014)

Socio-demographic, pattern of presentation and management outcome of breast cancer in a semi-urban tertiary health institution
por: Olaogun, Julius Gbenga, et al.
Publicado: (2020)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
por: Sonbul, Sultan N, et al.
Publicado: (2017)

Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells
por: Pannu, V, et al.
Publicado: (2014)

Perspectives and Attitudes towards the Functional and Safety Aspects of Seaweeds for Edible Applications in India
por: Gajaria, Tejal K., et al.
Publicado: (2021)

Clinicopathologic and molecular predictors of axillary lymph node metastasis in early-stage breast cancer: a mathematical predictive model
por: Aleskandarany, MA, et al.
Publicado: (2010)

Quadruple-negative breast cancer: novel implications for a new disease
por: Bhattarai, Shristi, et al.
Publicado: (2020)

Quadruple-Negative Breast Cancer: An Uneven Playing Field
por: Saini, Geetanjali, et al.
Publicado: (2020)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity
por: Haynes, Talaijha, et al.
Publicado: (2022)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
por: Johnston, Simon J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d999ru3n5hp46125l9v8av20jh